a genetic medicines company, which focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with AURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then AURA could also see price increases.
Ticker / NAME | Correlation To GBIO | 1D Price Change % | ||
---|---|---|---|---|
GBIO | 100% | -6.03% | ||
AURA - GBIO | 47% Loosely correlated | -2.47% | ||
ATNM - GBIO | 46% Loosely correlated | -3.94% | ||
ABOS - GBIO | 46% Loosely correlated | -0.51% | ||
INZY - GBIO | 46% Loosely correlated | -2.65% | ||
EDIT - GBIO | 45% Loosely correlated | +2.70% | ||
More |